Loading...
Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
Objective: Perampanel is an approved anti-seizure drug. A new formulation of perampanel fine granules (FG; 1% perampanel) has been developed for patients who are unable to take tablets. Bioequivalence between the 4-mg FG and tablet perampanel formulations, as well as their safety and tolerability, w...
Na minha lista:
| Udgivet i: | Int J Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dustri-Verlag Dr. Karl Feistle
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7659282/ https://ncbi.nlm.nih.gov/pubmed/32870153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP203781 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|